| # | Drug | Count |
|---|---|---|
| 0 | EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, AND TENOFOVIR ALAFENAMIDE | 1 |
| 1 | VELPATASVIR AND SOFOSBUVIR | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, AND TENOFOVIR ALAFENAMIDE | 1 | 0.0003 |
| 1 | VELPATASVIR AND SOFOSBUVIR | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hepatitis C Virus NS5A Inhibitor [EPC] | 1 | 0.0000 |
| 1 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 2 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |